UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)

HPB (Oxford, England), 2014-04, Vol.16 (4), p.350-356

2014

Volltextzugriff (PDF)

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The lancet. Gastroenterology & hepatology, 2022-03, Vol.7 (3), p.208-218

2022

Volltextzugriff (PDF)

The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma

Annals of surgical oncology, 2013-12, Vol.20 (Suppl 3), p.500-508

2013

Volltextzugriff (PDF)

Novel targeted and sustained drug delivery therapy for localized pancreatic cancer: Validation in porcine models and minimally invasive surgical feasibility in human cadavers

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16747-e16747

2020

Volltextzugriff (PDF)

Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4106-4106

2021

Volltextzugriff (PDF)

Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS4670-TPS4670

2020

Volltextzugriff (PDF)

Pattern of recurrence after curative resection of stage I-III duodenal adenocarcinoma

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.794-794

2020

Volltextzugriff (PDF)

The effect of antibiotic use on survival of patients with resected pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15773-e15773

2019

Volltextzugriff (PDF)

Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.4599-4599

2020

Volltextzugriff (PDF)

Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.486-486

2020

Volltextzugriff (PDF)

LUNA: A randomized phase II trial of liver resection plus chemotherapy or chemotherapy alone in patients with unresectable lung and resectable liver metastases from colorectal adenocarcinoma

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS3625-TPS3625

2017

Volltextzugriff (PDF)

Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4098-4098

2019

Volltextzugriff (PDF)

Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS2650-TPS2650

2019

Volltextzugriff (PDF)

Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15609-e15609

2019

Volltextzugriff (PDF)

First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.369-369

2018

Volltextzugriff (PDF)

Unresectable locally advanced cholangiocarcinoma treated with definitive radiation and gemcitabine

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15127-e15127

2015

Volltextzugriff (PDF)

Neuroendocrine neoplasm DFP report

Abdominal radiology (New York), 2021-02, Vol.46 (2), p.401-402

2021

Volltextzugriff (PDF)

Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.197-197

2015

Volltextzugriff (PDF)

Neoadjuvant nab -paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.328-328

2016

Volltextzugriff (PDF)

Defining the optimal timing of adjuvant therapy for resected pancreatic cancer: A statewide cancer registry analysis

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.406-406

2015

Volltextzugriff (PDF)

Effect of complications after pancreaticoduodenectomy on adjuvant therapy utilization and survival in pancreatic cancer

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.422-422

2015

Volltextzugriff (PDF)

Neoadjuvant chemoradiation versus surgery first for resectable pancreatic head adenocarcinoma: An economic and outcome analysis

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.156-156

2012

Volltextzugriff (PDF)

Use of operability classifications to predict outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.293-293

2012

Volltextzugriff (PDF)

Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis

Journal of clinical oncology, 2012-02, Vol.30 (4_suppl), p.629-629

2012

Volltextzugriff (PDF)

Conditional survival analysis of hepatocellular carcinoma

Journal of surgical oncology, 2020-09, Vol.122 (4), p.684-690

2020

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(20)
Surgery
(18)
Female
(15)
Male
(14)
Aged
(13)
Middle Aged
(13)
Oncology
(13)
Pancreatic Cancer
(11)
Pancreatic Neoplasms - Therapy
(10)
Retrospective Studies
(10)
Adult
(9)
Aged, 80 And Over
(9)
Medicine
(9)
Medicine & Public Health
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Pancreatic Neoplasms - Pathology
(8)
Pancreatic Neoplasms - Mortality
(7)
Carcinoma, Pancreatic Ductal - Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma

Novel targeted and sustained drug delivery therapy for localized pancreatic cancer: Validation in porcine models and minimally invasive surgical feasibility in human cadavers

Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers

Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) in pancreatic cancer

Pattern of recurrence after curative resection of stage I-III duodenal adenocarcinoma

The effect of antibiotic use on survival of patients with resected pancreatic ductal adenocarcinoma

Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC

Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC

LUNA: A randomized phase II trial of liver resection plus chemotherapy or chemotherapy alone in patients with unresectable lung and resectable liver metastases from colorectal adenocarcinoma

Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC

Adoptive transfer of tumor-infiltrating lymphocytes in patients with sarcomas, ovarian, and pancreatic cancers

Outcomes and patterns of failures after hypofractionated radiation therapy for intrahepatic cholangiocarcinoma

First line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma

Unresectable locally advanced cholangiocarcinoma treated with definitive radiation and gemcitabine

Neuroendocrine neoplasm DFP report

Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review

Neoadjuvant nab -paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX

Defining the optimal timing of adjuvant therapy for resected pancreatic cancer: A statewide cancer registry analysis

Effect of complications after pancreaticoduodenectomy on adjuvant therapy utilization and survival in pancreatic cancer

Neoadjuvant chemoradiation versus surgery first for resectable pancreatic head adenocarcinoma: An economic and outcome analysis

Use of operability classifications to predict outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy

Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control analysis

Conditional survival analysis of hepatocellular carcinoma

Suchergebnisse filtern